Malignancy following heart transplantation: differences in incidence and prognosis between sexes – a multicenter cohort study
- 22 January 2021
- journal article
- research article
- Published by Frontiers Media SA in Transplant International
- Vol. 34 (5) , 882-893
Abstract
Male patients are at increased risk for developing malignancy post‐heart transplantation (HT); however, real incidence and prognosis in both genders remains unknown. The aim of this study was to assess differences in incidence and mortality related to malignancy between genders in a large cohort of HT patients. Incidence and mortality rates were calculated for all tumors, skin cancers (SCs), lymphoma and non‐skin solid cancers (NSSCs) as well as survival since first diagnosis of neoplasia. 5865 patients (81.6% male) were included. Total incidence rates for all tumors, SCs and NSSCs were lower in females (all tumors: 25.7 vs. 44.8 per 1000 person‐years; Rate Ratio (RR) 0.68, (0.60–0.78), p<0.001). Mortality rates were also lower in females for all tumors (94.0 (77.3‐114.3) vs. 129.6 (120.9‐138.9) per 1000 person‐years; RR 0.76, (0.62‐0.94), p=0.01) and for NSSCs (125.0 (95.2‐164.0) vs 234.7 (214.0‐257.5) per 1000 person‐years; RR 0.60 (0.44–0.80), p=0.001), albeit not for SCs or lymphoma. Female sex was associated to a better survival after diagnosis of malignancy (log‐rank p test=0.0037; HR 0.74 (0.60‐0.91), p=0.004). In conclusion, incidence of malignancies post‐HT is higher in males than in females, especially for SCs and NSSCs. Prognosis after cancer diagnosis is also worse in males.Keywords
Funding Information
- Instituto de Salud Carlos III
This publication has 30 references indexed in Scilit:
- Spectrum of Cancer Risk Among US Solid Organ Transplant RecipientsJAMA, 2011
- Skin cancer in solid organ transplant recipients: Advances in therapy and managementJournal of the American Academy of Dermatology, 2011
- Lung Cancer after Heart Transplantation: Results from a Large Multicenter RegistryAmerican Journal of Transplantation, 2011
- Incidence and Risk Factors for Nonmelanoma Skin Cancer After Heart TransplantationTransplantation Proceedings, 2010
- Survival Differences by Gender for Resected Non-small Cell Lung Cancer: A Retrospective Analysis of 12,509 Cases in a Japanese Lung Cancer Registry StudyJournal of Thoracic Oncology, 2010
- The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipientsThe Journal of Heart and Lung Transplantation, 2010
- Malignancy After Heart Transplantation: Incidence, Prognosis and Risk FactorsAmerican Journal of Transplantation, 2008
- Mycophenolate Mofetil and Risk of Developing Malignancy After Orthotopic Heart Transplantation: Analysis of the Transplant Registry of the International Society for Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2006
- Immunosuppressive Drugs and the Risk of Cancer after Organ TransplantationNew England Journal of Medicine, 2005
- Smoking and cancerThe American Journal of Medicine, 1992